Search Results (99)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. | Academic Article |
Why?
|
| CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR. | Academic Article |
Why?
|
| Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma. | Academic Article |
Why?
|
| Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race. | Academic Article |
Why?
|
| Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas. | Academic Article |
Why?
|
| Serous-like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. | Academic Article |
Why?
|
| Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma. | Academic Article |
Why?
|
| Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals. | Academic Article |
Why?
|
| The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. | Academic Article |
Why?
|
| GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor. | Academic Article |
Why?
|
| Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma. | Academic Article |
Why?
|
| Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. | Academic Article |
Why?
|
| Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women. | Academic Article |
Why?
|
| The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma. | Academic Article |
Why?
|
| Brubaker, Lindsay | Person |
Why?
|